[1] |
ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin.
Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
|
[2] |
SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing.
Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
|
[3] |
SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui.
Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
|
[4] |
YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan.
Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
|
[5] |
LIANG Jie.
172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
|
[6] |
LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji.
Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
|
[7] |
ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing.
Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
|
[8] |
CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing.
One Case of Acute Withdrawal Syndrome Caused by Naloxone
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.
|
[9] |
YANG Xin, YANG Baochun, YANG Yang, SHAO Huan.
One Case of Multiple Endocrine Adverse Effect Caused by Sintilimab
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 947-949.
|
[10] |
XIE Rui, GENG Zihan, BAO Lei, ZHAO Ronghua, LI Shuran, SUN Qiyue, WANG Xinwei, ZHANG Jingsheng, CUI Xiaolan, GUO Shanshan, SUN Jing.
Research Progress in Pharmacological Actions, Mechanisms, Structural Modifications and Targeted Formulations of Ribavirin
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 950-955.
|
[11] |
WANG Yinghe, LI Mingqi, ZHAO Xiaolu, MA Yuehong.
Different Functions of Autophagy in Diseased Livers
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 956-960.
|
[12] |
QI Yujie, WANG Xin, ZHANG Jiahui, MA Enlong, GENG Xingchao.
Research Progress in Integration Sites for Cellular and Gene Therapy Products
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 721-727.
|
[13] |
YANG Yifan, YANG Yanwei, ZHANG Di, XIE Yin, ZHANG Yong, CHEN Xulin, GAO Sutao, GENG Xingchao, QU Zhe.
Quality Control and Test Methods of Human Induced Pluripotent Stem Cells
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 728-734.
|
[14] |
LIU Yi, WU Jingfang, QIN Lin, CHEN Junmiao, ZHANG Juan, CHEN Hua, NING Xiao, CAO Jin.
Related Substances in Efavirenz Tablets Based on HPLC-TRIPLE QUAD-MS/MS Technology
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 749-754.
|
[15] |
LI Yaolei, JIN Hongyu, CHENG Xianlong, WEI Feng.
Quantitative Characterization and Chemometric Discrimination of 24 Coumarin Constituents in Peucedanum Medicinal Materials
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 755-762.
|